We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
entrinsic bioscience (EBS), a company pioneering a next generation protein modulation technology, announced that it has been granted U.S. Patent No. (USPN) 10,758,507 ('507 patent) for novel therapeutic formulations in the treatment of a range of ...